Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    15851647 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Comparing the Effects of Spironolactone With Chlortalidone on LV Mass in Patients With CKD
Conditions: Renal Insufficiency, Chronic;   Cardio-Renal Syndrome
Interventions: Drug: Spironolactone;   Drug: Chlortalidone
2 Completed Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Conditions: Cardiovascular Diseases;   Coronary Disease;   Diabetes Mellitus;   Heart Diseases;   Hypercholesterolemia;   Hypertension;   Myocardial Infarction;   Myocardial Ischemia;   Heart Failure
Interventions: Drug: Inhibitors, ACE;   Drug: amlodipine;   Drug: lisinopril;   Drug: doxazosin;   Drug: chlorthalidone;   Drug: pravastatin;   Behavioral: diet, fat-restricted

Study has passed its completion date and status has not been verified in more than two years.